21 CFR 606.40
Facilities.
- Inspections citing it: 142
- Of those classified, ended OAI: 2%
- Last cited: FY2026
Inspections Citing It by Fiscal Year
Sites in and outside the US, FY2017 to Oct 20, 2026.
Paragraphs Cited
As FDA posts them, all years.
- 606.40(a)(1)
- 72 · Provide space for examination
- 606.40
- 47 · Clean & orderly
- 606.40(c)
- 13 · Provide adequate handwashing
- 606.40(a)(6)
- 5 · Provide space for quarantine of unsuitable for use items
- 606.40(b)
- 5 · Adequate lighting, ventilation, and screening
Regulation Text
eCFR, as of Nov 6, 2026Facilities shall be maintained in a clean and orderly manner, and shall be of suitable size, construction and location to facilitate adequate cleaning, maintenance and proper operations. The facilities shall:
(a) Provide adequate space for the following when applicable:
(1) Private and accurate examinations of individuals to determine their eligibility as blood donors.
(2) The withdrawal of blood from donors with minimal risk of contamination, or exposure to activities and equipment unrelated to blood collection.
(3) The storage of blood or blood components pending completion of tests.
(4) The quarantine storage of blood or blood components in a designated location pending repetition of those tests that initially gave questionable serological results.
(5) The storage of finished products prior to distribution.
(6) The quarantine storage, handling and disposition of products and reagents not suitable for use.
(7) The orderly collection, processing, compatibility testing, storage and distribution of blood and blood components to prevent contamination.
(8) The adequate and proper performance of all steps in plasmapheresis, plateletpheresis and leukapheresis procedures.
(9) The orderly conduction of all packaging, labeling and other finishing operations.
(b) Provide adequate lighting, ventilation and screening of open windows and doors.
(c) Provide adequate, clean, and convenient handwashing facilities for personnel, and adequate, clean, and convenient toilet facilities for donors and personnel. Drains shall be of adequate size and, where connected directly to a sewer, shall be equipped with traps to prevent back-siphonage.
(d) Provide for safe and sanitary disposal for the following:
(1) Trash and items used during the collection, processing and compatibility testing of blood and blood components.
(2) Blood and blood components not suitable for use or distribution.
Recently Cited Sites
Newest inspections citing this section; each opens the site- BioLife Plasma Services L.P.United States · Jun 25, 2026
- The American National Red CrossUnited States · Apr 8, 2026
- LifeSouth Community Blood Centers IncUnited States · Feb 11, 2026
- Olgam Life LLCUnited States · Jan 22, 2026
- BioLife Plasma Services LPUnited States · Dec 5, 2025
- VitalantUnited States · Feb 7, 2025
- Carter BloodCare - TexomaUnited States · Aug 23, 2024
Counts are inspections with posted citations that cite any paragraph of the section, once per inspection, from FDA's Data Dashboard. OAI share is over inspections FDA finally classified. Text from eCFR, the official online CFR. FDA Data Dashboard and eCFR